Vaxcyte, Inc. — Director's Dealing 2022

Feb 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-11-08

Reporting Person: Dhaliwal Harpreet S. (SVP Cml Mfg & Supply Chain)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-08	Stock Option (Right to Buy)	$25.06	A	100000	Acquired	2031-11-07	Common Stock (100000)	Direct

Footnotes

F1: 1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date